{"url_path":"/sec/ptct/8-k/2026-06-18/item-3-02","section_key":"item-3-02","section_title":"Item 3.02 **","topic":"sec","document":{"doc_type":"8-K","doc_date":"2026-06-18","source_url":"https://www.sec.gov/Archives/edgar/data/1070081/0001104659-26-075731-index.html","accession_number":"0001104659-26-075731","cik":"0001070081","ticker":"PTCT","issuer_name":"PTC THERAPEUTICS, INC.","edgar_url":"https://www.sec.gov/Archives/edgar/data/1070081/0001104659-26-075731-index.html","primary_entity_key":"0001070081","primary_entity_name":"PTC THERAPEUTICS, INC."},"word_count":126,"has_tables":true,"body_markdown":"**Item 3.02.**\n**Unregistered Sales of Equity Securities.**\n\n \n\nThe information set forth in Item 1.01 above is incorporated herein\nby reference.\n\n \n\nThe Notes were sold to the Initial Purchasers in reliance on the exemption\nfrom the registration requirements provided by Section 4(a)(2) of the Securities Act for resale to persons reasonably believed\nto be qualified institutional buyers pursuant to Rule 144A of the Securities Act. The Company does not intend to file a registration\nstatement for the resale of the Notes or any Common Stock issuable upon conversion of the Notes. Additional information pertaining to\nthe Notes and the shares of Common Stock issuable upon conversion of the Notes is contained in Item 1.01 of this Current Report on Form 8-K\nand is incorporated herein by reference."}